Changes in the Distribution of Pathogens Causing Meningoencephalitis Before and During the COVID-19 Pandemic

Clinical Laboratory
|September 11, 2024
PubMed
Abstract

Insights

COVID-19 measures significantly reduced meningoencephalitis (ME) pathogen rates, particularly in children aged three and older. While enterovirus cases declined, bacterial infections like S. agalactiae, S. pneumoniae, and E. coli K1 increased.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Epidemiology

Background:

  • Infectious meningoencephalitis (ME) is a significant global health issue, primarily caused by viruses.
  • COVID-19 mitigation strategies impacted the incidence of various infectious diseases.

Purpose of the Study:

  • To evaluate the effect of COVID-19 mitigation measures on ME-causing pathogens.
  • To analyze changes in pathogen distribution across different age groups during the pandemic.

Main Methods:

  • Retrospective analysis of pathogen-positive ME cases comparing pre-pandemic (P-1) and pandemic (P-2) periods.
  • Utilized molecular diagnostic methods on cerebrospinal fluid samples from all age groups.
  • Compared pathogen positivity rates and distribution patterns between the two periods.

Main Results:

  • Overall ME pathogen positivity decreased significantly from 22.0% in P-1 to 7.3% in P-2.
  • A notable decline was observed in children aged three years and older.
  • Enterovirus cases decreased, while Varicella Zoster Virus and Herpes Simplex Virus-2 increased; bacterial ME (S. agalactiae, S. pneumoniae, E. coli K1) significantly rose.

Conclusions:

  • COVID-19 mitigation measures substantially altered ME-causing agent positivity and distribution, especially in individuals aged three and above.
  • The impact was not uniform across all pathogens and age demographics.